Evidence-Based Complementary and Alternative Medicine / 2014 / Article / Tab 1

Research Article

The Comparative Study on Expression of SIRT1 Signal Transduction by Xuefuzhuyu Capsule

Table 1


Target geneThe primer sequencesAmplification length (bp)

P53Upstream: 5′-GCAGTTCCTCTTCCTGCAGTACTC-3′;241
Downstream: 5′-AAC CAGACCTCAGGCGGCTCATAG-3′
NF- BUpstream: 5′-CGATCTGTTTCCCCT CATCT-3′175
Downstream: 5′-ATTGGGTGCGTCTTAGTGGT-3′
FOX01Upstream: 5′-AACCAGCTCAAAT GCTAGTACCATC-3′198
Downstream: 5′-CAGAAGGTTCTCCATGTTTTTCT GGA-3′
FOX03Upstream: 5′-TACACGGCTTGCTTACGG-3′423
Downstream: 5′-GGG TTC AGA ACG AAG GGA CT-3′;
FOX04Upstream: 5-TCATCAGCCAGGCCATTGAA-3′174
Downstream: 5′-TGCTGTGCAAAGACAGGTTGTG-3′;
Sirt1-2Upstream: 5′-TTTCAGAACCACCAAAGCG-3′206
Downstream: 5′-TCCCACAGGAAACAGAAACC-3′
-ActinUpstream: 5-GAG ACC TTC AAC ACC CCA GCC-3263
Downstream: 5-AAT GTC ACG CAC GAT TTC CC-3

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.